Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-<i>n</i>-butylbromide (Buscopan) During Gastrointestinal Endoscopy.

Forbes, Nauzer; Frehlich, Levi; Borgaonkar, Mark; Leontiadis, Grigorios I; Tse, Frances

Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy.

Forbes, Nauzer; Frehlich, Levi; Borgaonkar, Mark; Leontiadis, Grigorios I; Tse, Frances.

Afiliação

Forbes N; Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Frehlich L; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Borgaonkar M; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Leontiadis GI; Faculty of Medicine, Memorial University, St John's, Newfoundland and Labrador, Canada.
Tse F; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.

J Can Assoc Gastroenterol ; 4(6): 259-268, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34877465

Palavras-chave

Adverse events; Buscopan; Endoscopy; Quality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: J Can Assoc Gastroenterol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google